- ISIN
- US26923G2021
- CUSIP
- 26923G202
- Inception Date
- Dec 17, 2014
- Region
- North America (U.S.)
- Category
- Health & Biotech Equities
- Leveraged
- 1x (No leverage)
- Index Tracked
- LifeSci Biotechnology Products Index
- Distribution Policy
- Accumulating
- Asset Class
- Equity
- Asset Class Size
- Multi-Cap
- Asset Class Style
- Growth
- Assets Under Management
- $79M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
BBP Performance Chart
Virtus LifeSci Biotech Products ETF (BBP) is up 14.7% since the beginning of the year. BBP is currently trading at $92 per share. Investors who bought $1,000 worth of BBP shares 5 years ago would now be looking at an investment worth $1,709.
Loading charts...
Returns By Period
Virtus LifeSci Biotech Products ETF (BBP) has returned 14.66% so far this year and 57.44% over the past 12 months. Over the last ten years, BBP has had an annualized return of 13.55%, just under the S&P 500 Index benchmark’s 13.88%.
Virtus LifeSci Biotech Products ETF
- 1D
- 1.80%
- 1M
- 6.41%
- YTD
- 14.66%
- 6M
- 12.08%
- 1Y
- 57.44%
- 3Y*
- 19.92%
- 5Y*
- 11.32%
- 10Y*
- 13.55%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
BBP Monthly Returns History
Based on dividend-adjusted daily data since Dec 17, 2014, BBP's average daily return is +0.06%, while the average monthly return is +1.18%. At this rate, an investment would double in approximately 4.9 years.
Historically, 60% of months were positive and 40% were negative. The best month was Jan 2019 with a return of +17.9%, while the worst month was Jan 2016 at -22.2%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 4 months.
On a daily basis, BBP closed higher 52% of trading days. The best single day was Nov 9, 2016 with a return of +10.9%, while the worst single day was Mar 16, 2020 at -12.9%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 2.14% | 4.01% | -2.16% | 2.06% | 2.13% | 5.83% | 14.66% | ||||||
| 2025 | 3.86% | -1.20% | -4.83% | 0.47% | -4.74% | 3.79% | 5.67% | 9.42% | 3.93% | 6.66% | 7.32% | -0.22% | 33.15% |
| 2024 | -1.15% | 4.01% | -5.22% | -6.44% | 6.71% | 4.01% | 6.64% | 2.36% | -2.06% | 0.70% | 3.78% | -8.61% | 3.32% |
| 2023 | 5.38% | -4.65% | -0.48% | 4.45% | 0.51% | 1.72% | 4.49% | -3.61% | -5.60% | -6.77% | 9.46% | 13.79% | 17.88% |
| 2022 | -11.85% | -2.27% | 3.28% | -11.18% | -2.05% | 8.98% | 3.08% | 11.35% | -4.17% | 2.99% | 7.41% | -1.74% | 0.85% |
| 2021 | 6.11% | -2.78% | -4.62% | 2.61% | -3.73% | 3.18% | -5.24% | 3.90% | -3.12% | 1.68% | -6.94% | 1.45% | -8.17% |
Benchmark Metrics
Virtus LifeSci Biotech Products ETF has an annualized alpha of 3.03%, beta of 0.93, and R2 of 0.35 versus S&P 500 Index. Calculated based on daily prices since December 17, 2014.
- This ETF participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (93.46%) than losses (93.38%) - typical of diversified or defensive assets.
- R2 of 0.35 means the benchmark explains less than half of this ETF's behavior - treat beta with caution or consider switching to a more representative benchmark.
- Alpha
- 3.03%
- Beta
- 0.93
- R²
- 0.35
- Upside Capture
- 93.46%
- Downside Capture
- 93.38%
Expense Ratio
BBP has an expense ratio of 0.79%, placing it in the medium range.
Return for Risk
Risk / Return Rank
BBP ranks 81 for risk / return — in the top 81% of ETFs on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Virtus LifeSci Biotech Products ETF (BBP) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BBP | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.38 | ||
| Sortino ratioReturn per unit of downside risk | +0.55 | ||
| Omega ratioGain probability vs. loss probability | 1.39 | 1.37 | +0.02 |
| Calmar ratioReturn relative to maximum drawdown | 6.22 | 2.78 | +3.44 |
| Martin ratioReturn relative to average drawdown | 19.33 | 12.44 | +6.90 |
Dividends
Dividend History
Virtus LifeSci Biotech Products ETF provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.07 | $0.00 | $0.40 |
Dividend yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.18% | 0.00% | 1.29% |
Monthly Dividends
The table displays the monthly dividend distributions for Virtus LifeSci Biotech Products ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Virtus LifeSci Biotech Products ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Virtus LifeSci Biotech Products ETF was 44.32%, occurring on May 9, 2022. Recovery took 452 trading sessions.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
Bear market2022 | -44.32%May 2022 | 1y 2mo | 1y 9mo | 3y 18dFeb 2021 - Feb 2024 |
2016 bear market2016 | -40.49%Feb 2016 | 6mo 25d | 12mo 4d | 1y 6moJul 2015 - Feb 2017 |
COVID crash2020 | -32.25%Mar 2020 | 1y 8mo | 1mo 26d | 1y 10moJul 2018 - May 2020 |
2025 selloff2025 | -26.09%Apr 2025 | 5mo | 4mo 25d | 9mo 25dNov 2024 - Sep 2025 |
2024 correction2024 | -19.84%Apr 2024 | 1mo 20d | 2mo 28d | 4mo 18dFeb 2024 - Jul 2024 |
Drawdown Indicators
| BBP | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -44.32% | -56.78% | +12.46% |
Max Drawdown (1Y)Largest decline over 1 year | -9.28% | -9.10% | -0.18% |
Max Drawdown (3Y)Largest decline over 3 years | -26.09% | -18.90% | -7.19% |
Max Drawdown (5Y)Largest decline over 5 years | -37.89% | -25.43% | -12.46% |
Max Drawdown (10Y)Largest decline over 10 years | -44.32% | -33.92% | -10.40% |
Current DrawdownCurrent decline from peak | 0.00% | -1.80% | +1.80% |
Average DrawdownAverage peak-to-trough decline | -11.98% | -10.71% | -1.27% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.98% | 2.03% | +0.95% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Build a portfolio with BBP
Add Virtus LifeSci Biotech Products ETF to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with BBP